Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1658070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Junpu Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Laboratory, Tianjin Chest Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Mannans, Antigens, Fungal, Luminescent Measurements, Aspergillus. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Invasive pulmonary aspergillosis (IPA) poses significant diagnostic challenges in immunocompromised patients, with galactomannan (GM) detection serving as a key biomarker. Existing Platelia™ GM enzyme-linked immunosorbent assay (ELISA) faces limitations in throughput and turnaround time.
Methods
We developed a magnetic bead-based chemiluminescent enzyme immunoassay (CLEIA) for GM detection in serum/bronchoalveolar lavage fluid (BALF).
Results
Optimized CLEIA parameters enabled 30-min analysis versus 120-min for ELISA. Validation with 241 clinical specimens demonstrated robust analytical performance: diagnostic thresholds of ≥ 0.20 CLEIA Units for serum and BALF matrices (ROC-AUC 0.87, p<0.0001), analytical sensitivity of 0.50 ng/mL, and precision with ≤14.40% total CV, and no hook effect ≤200 ng/mL. Method comparison against the Platelia ELISA revealed 86.72% overall diagnostic agreement (Cohen’s k=0.72), while cross-reactivity analyses indicated specificity limitations exclusively with Histoplasma -positive specimens, consistent with parallel GM ELISA results.
Discussion
This assay enables 75% processing time reduction with uncompromised diagnostic accuracy, positioning it as a high-throughput alternative for rapid IA screening in high-risk cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Clinical Laboratory, Tianjin Chest Hospital, Tianjin, China.
- Department of Medical Ultrasound, Tianjin Medical University General Hospital, Tianjin, China.
Zitieren
APA
Li, J., & Guo, Y. (2025). Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1658070
Vancouver
Li J, Guo Y. Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1658070
BibTeX
@article{Li2025,
author = {Li, Junpu and Guo, Yan},
title = {Establishment of sensitive sandwich−type chemiluminescence immunoassay for Aspergillus galactomannan antigen},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1658070}
}
EUVIMED